%D8%AF%D8%A7%D8%A1_%D8%A7%D9%84%D9%85%D8%AB%D9%82%D8%A8%D9%8A%D8%A7%D8%AATripanosomosiTrypanosomiasisTripanosomiasi%D8%AA%D8%B1%DB%8C%D9%BE%D8%A7%D9%86%D9%88%D8%B2%D9%88%D9%85%DB%8C%D8%A7%D8%B2TrypanosomiaseTripineas%C3%B3imi%C3%A1is%E0%A4%9F%E0%A5%8D%E0%A4%B0%E0%A4%BF%E0%A4%AA%E0%A5%88%E0%A4%A8%E0%A5%8B%E0%A4%B8%E0%A5%8B%E0%A4%AE%E0%A4%BF%E0%A4%AF%E0%A4%BE%E0%A4%B8%E0%A4%BF%E0%A4%B8%D5%8F%D6%80%D5%AB%D5%BA%D5%A1%D5%B6%D5%B8%D5%BD%D5%B8%D5%B4%D5%B8%D5%A6%D5%B6%D5%A5%D6%80Tripanosomiasis%E3%83%88%E3%83%AA%E3%83%91%E3%83%8E%E3%82%BD%E3%83%BC%E3%83%9E%E7%97%87%D0%A2%D1%80%D0%B8%D0%BF%D0%B0%D0%BD%D0%BE%D1%81%D0%BE%D0%BC%D0%BE%D0%B7%E0%B2%9F%E0%B3%8D%E0%B2%B0%E0%B2%BF%E0%B2%AA%E0%B2%A8%E0%B3%8A%E0%B2%B8%E0%B3%8B%E0%B2%AE%E0%B2%BF%E0%B2%AF%E0%B2%BE%E0%B2%B8%E0%B2%BF%E0%B2%B8%E0%B3%8D%ED%8A%B8%EB%A6%AC%ED%8C%8C%EB%85%B8%EC%86%8C%EB%A7%88%EC%A6%9DTripanosomoz%C4%97TrypanosomiasisTrypanosomozaTripanossom%C3%ADase%D0%A2%D1%80%D0%B8%D0%BF%D0%B0%D0%BD%D0%BE%D1%81%D0%BE%D0%BC%D0%BE%D0%B7%D1%8BTrypanosomiasisTrypanosomiasis%E0%B0%9F%E0%B1%8D%E0%B0%B0%E0%B1%88%E0%B0%AA%E0%B0%BE%E0%B0%A8%E0%B1%8B%E0%B0%B8%E0%B1%8B%E0%B0%AE%E0%B0%BF%E0%B0%AF%E0%B0%B8%E0%B0%BF%E0%B0%B8%E0%B1%8D%D0%A2%D1%80%D0%B8%D0%BF%D0%B0%D0%BD%D0%BE%D1%81%D0%BE%D0%BC%D0%BE%D0%B7%D0%B8Q2443552
about
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, UgandaProspective Evaluation of an RDT to Screen for Gambiense HAT and Diagnose P. Falciparum MalariaRapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal StudyPivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With FoodHuman African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the FexinidazoleHuman African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158Clinical Study to Assess the Tolerability, Feasibility and Effectiveness of Nifurtimox and Eflornithine (NECT) for the Treatment of Trypanosoma Brucei Gambiense Human African Trypanosomiasis (HAT) in the Meningo-encephalitic PhaseTrial of DB289 for the Treatment of Stage I African TrypanosomiasisDiagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP2 Passive Case DetectionBioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market FormulationStudy to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas DiseaseCHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal StudyA Trial of DB289 for the Treatment of Stage I African TrypanosomiasisRandomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African TrypanosomiasisEfficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African TrypanosomiasisBENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' DiseaseDiagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: Early Test-of-cureEfficacy and Safety of Fexinidazole in Patients With Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei RhodesienseProspective Study on Efficacy and Safety of SCYX-7158 in Patients Infected by Human African Trypanosomiasis Due to T.b. GambienseFexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any StageDiagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination MonitoringADME Study of Acoziborole in Healthy Subjects
P1050
P2175
Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responsesTrypanosomiasis vector control in Africa and Latin AmericaChemotherapy for second-stage Human African trypanosomiasisChemotherapy for second-stage Human African trypanosomiasisChemotherapy of second-stage Human African trypanosomiasisOptions for field diagnosis of human african trypanosomiasisManagement of trypanosomiasis and leishmaniasisThe history of African trypanosomiasisEvaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central AfricaTHE TREATMENT OF SLEEPING SICKNESS AND OTHER TRYPANOSOMIASES BY THE ATOXYL AND MERCURY METHODChemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasisEvaluation of a polymerase chain reaction assay for the diagnosis of bovine trypanosomiasis and epidemiological surveillance in BoliviaWhat can we hope to gain for trypanosomiasis control from molecular studies on tsetse biology ?Historical aspects of American trypanosomiasis (Chagas' disease)Neemazal ® as a possible alternative control tool for malaria and African trypanosomiasis?Host Intracellular Signaling Events and Pro-inflammatory Cytokine Production in African TrypanosomiasisTsetse Flies (Glossina) as Vectors of Human African Trypanosomiasis: A ReviewA Mother's Gift: Congenital Transmission of Trypanosoma and Leishmania SpeciesOverview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years?A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasisContemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: reviewA literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness")Challenges towards the elimination of Human African Trypanosomiasis in the sleeping sickness focus of Campo in southern CameroonHuman African trypanosomiasis in non-endemic countries (2000-2010)Recent developments in drug discovery for leishmaniasis and human African trypanosomiasisGlossina fuscipes populations provide insights for human African trypanosomiasis transmission in UgandaEpidemiology of human African trypanosomiasisImprovements on restricted insecticide application protocol for control of Human and Animal African Trypanosomiasis in eastern UgandaIn vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasisMelarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasisImplications of Heterogeneous Biting Exposure and Animal Hosts on Trypanosomiasis brucei gambiense Transmission and ControlSome current problems in the sero-immunology of trypanosomiasis in relation to the epidemiology and control of the diseaseControl of the African trypanosomiases with special reference to land useAlternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P.A targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’IvoireExploiting the Achilles' heel of membrane trafficking in trypanosomesPreventing the transmission of American trypanosomiasis and its spread into non-endemic countriesAPOL1 toxin, innate immunity, and kidney injuryAmerican trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategiesA systematic strategy for large-scale analysis of genotype phenotype correlations: identification of candidate genes involved in African trypanosomiasis
P921
Q61918126-0F98CB57-90DE-4C56-B5CA-7AA9BAFA96B9Q63403992-228A028C-F255-4DBF-A798-D058E56508A6Q63844762-F4E5C492-7E68-4FC4-81DB-CD40DDEF8975Q64609776-B7E77B2B-7114-476A-8D75-390E098079AEQ64641478-2281A7A7-263A-4BF1-9327-DCB1E2E191D7Q64647248-67911EEF-CC27-4113-A680-118BB689AA37Q64662780-22993BD4-D4B3-4A15-9A70-DEB8CDA91E1EQ64672527-FF11DC82-49DA-49BB-B749-118F096956E2Q64675674-115692D5-E722-40E0-BBD1-3C11A3039EA5Q64697326-A65B44CD-D777-4BFC-9712-A268651D4A65Q64807997-3853EBF1-FB92-4EAF-83AD-A82AA442158CQ65319334-038DEDBF-4C35-4666-A2C3-B075C7CBEB7CQ65343590-557BDC3C-DEC5-489E-964A-BCF16FC3124FQ65348025-75C57FD5-D39C-4E8D-9014-F8CEEF81F105Q65354588-DCA13C63-82BE-494B-BB08-4E1AC9417B0BQ65377576-038BD956-F7DF-46D5-B949-BCB39F190330Q65390852-2D855459-B885-4E9E-B2D3-D6EBF86244A7Q66029473-C8FA3522-0677-4770-9499-30298A7F03C0Q66031801-E6857C35-EA1B-4504-9F4F-7BE2514601FBQ66046762-553E62DF-B609-4F90-B5DB-D1399CAE3438Q66064656-B1F751BE-BEEE-427B-B299-2CB93725BA09Q66071909-903349E3-F398-4169-B951-48AF1C3401BCQ66074256-A47E03CC-8C64-4BF4-BA62-4FD1B168801DQ74282457-0BF2FE57-E45D-483E-A689-736C0A727C0AQ87076207-0738FB6E-1962-4A04-820F-502B692BC602
P1050
description
Erkrankung durch Trypanosomen
@de
Penyakit akibat protozoa Trypanosoma
@id
Tripanosomek eragindako gaixotasun parasitarioa
@eu
parasitic protozoa infectious ...... panosoma in animals and humans
@en
protozosjukdom som skuldast infeksjon av parasittiske protozoar i slekta Trypanosoma
@nn
група паразитарних захворювань
@uk
مرض معدٍ طفيلي ينجم عن عدوى بأحد طفيليات الأوّالي، تنتمي إلى جنس المثقبيات
@ar
name
Tripanosomiasis
@id
Tripanosomozė
@lt
Tripineasóimiáis
@ga
Trypanosomiasis
@de
Trypanosomiaza
@pl
clefyd cysgu
@cy
tripanosomiasi
@eu
tripanosomiasis
@es
tripanosomosi
@ca
tripanossomíase
@pt
type
label
Tripanosomiasis
@id
Tripanosomozė
@lt
Tripineasóimiáis
@ga
Trypanosomiasis
@de
Trypanosomiaza
@pl
clefyd cysgu
@cy
tripanosomiasi
@eu
tripanosomiasis
@es
tripanosomosi
@ca
tripanossomíase
@pt
altLabel
Trypanosomiases
@en
錐體蟲病
@zh
锥虫病
@zh
prefLabel
Tripanosomiasis
@id
Tripanosomozė
@lt
Tripineasóimiáis
@ga
Trypanosomiasis
@de
Trypanosomiaza
@pl
clefyd cysgu
@cy
tripanosomiasi
@eu
tripanosomiasis
@es
tripanosomosi
@ca
tripanossomíase
@pt
P2581
P3916
P486
P6366
P672
P1417
science/trypanosomiasis
P1995
P2176
P2581
P2888
P2892
P2924
P31
P373
Trypanosomiasis
P3827
trypanosomiasis
P3916
concept14952